PIM1 Recombinant Antibody, Cy5.5 Conjugated
Product Specifications
Background
Proto-oncogene with serine/threonine kinase activity involved in cell survival and cell proliferation and thus providing a selective advantage in tumorigenesis. Exerts its oncogenic activity through: the regulation of MYC transcriptional activity, the regulation of cell cycle progression and by phosphorylation and inhibition of proapoptotic proteins (BAD, MAP3K5, FOXO3) .
Synonyms
Oncogene PIM1; PIM; pim-1 kinase 44 kDa isoform; pim-1 oncogene; pim-1 oncogene (proviral integration site 1) ; PIM1.
Gene ID
5292
Swiss Prot
P11309
Cellular Locus
Cytoplasm, Nucleus, Cell membrane
Host
Rabbit
Cross Reactivity
Human, Mouse
Target
PIM1
Clonality
Recombinant
Isotype
IgG
Conjugation
Cy5.5
Source
KLH conjugated synthetic peptide derived from human PIM1
Applications
WB
Purification
Purified by Protein A.
Excitation Emission
675nm/694nm
Concentration
Lot dependent
Dilution
WB (1:300-5000)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
5292
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
302455-ML550 100 µL
FRA10AC1 (Protein FRA10AC1, FRA10AC1, C10orf4) (MaxLight 550) discontinued
Ask
View Details